middle.news
Could This Blood Test Revolutionize Early Detection of Esophageal Cancer?
9:30am on Thursday 5th of June, 2025 AEST
•
Healthcare
Read Story
Could This Blood Test Revolutionize Early Detection of Esophageal Cancer?
9:30am on Thursday 5th of June, 2025 AEST
Key Points
PromarkerEso achieves 91.4% sensitivity and 98.9% specificity in detecting esophageal adenocarcinoma
Test uses four glycoprotein biomarkers combined with patient data for risk scoring
Addresses major diagnostic gap where 90% of esophageal adenocarcinoma cases go undetected
Commercial launch imminent in Australia with plans for global expansion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE